Fundraising FoxSands Capital Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Codoxo builds a generative AI-driven Unified Cost Containment Platform for healthcare payers, government agencies, and pharmacy benefit managers to improve payment integrity and detect fraud, waste, and abuse.
AI & Machine LearningHealthtechSaaS
Musheer Ahmed(Founder)in
Co-investorsBrewer Lane VenturesEcho Health VenturesGRA VentureGray VenturesQED InvestorsService Provider Capital+4 more
Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.
BiotechDigital HealthHealthtechMedical DevicesMadison, US
Jonathan Oliner(Executive Officer)inManeesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)
Co-investorsARCH Venture PartnersNorthpond Ventures
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.
Digital HealthHardwareMedical DevicesDublin, IE
Co-investorsAndera PartnersGimvIreland Strategic Investment FundLightstone VenturesLongitude CapitalNew Enterprise Associates (NEA)+5 more
Hawk provides a cloud-native, multi-tenant SaaS platform for anti-money-laundering and financial compliance, processing billions of transactions in real time.
AI & Machine LearningCybersecurityFintechSaaSMunich, DE
Tobias Schweiger(Co-founder & CEO)inWolfgang Berner(Co-founder & Chief Product Officer)inMaximilian Riege(Chief Risk Officer)inEli Chamoun(President & Chief Revenue Officer)inBen Pannier(Chief Technology Officer)inDaniel Marshall(Chief Customer Officer)in
Co-investorsDN CapitalPICUS CAPITALRabo Corporate VenturingBlackFin Capital PartnersCoalitionMacquarie Capital
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in
Co-investorsAmzak HealthWellington ManagementAlgerBraidwellEssex Woodlands Healthcare PartnersREDMILE+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.